254 related articles for article (PubMed ID: 29248149)
1. Morphea in Childhood: An Update.
Aranegui B; Jiménez-Reyes J
Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):312-322. PubMed ID: 29248149
[TBL] [Abstract][Full Text] [Related]
2. Update on the classification and treatment of localized scleroderma.
Bielsa Marsol I
Actas Dermosifiliogr; 2013 Oct; 104(8):654-66. PubMed ID: 23948159
[TBL] [Abstract][Full Text] [Related]
3. [Morphea or juvenile localised scleroderma: Case report].
Strickler A; Gallo S; Jaramillo P; de Toro G
Rev Chil Pediatr; 2016; 87(4):279-83. PubMed ID: 26976080
[TBL] [Abstract][Full Text] [Related]
4. Morphea and Eosinophilic Fasciitis: An Update.
Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of morphea treatments and therapeutic algorithm.
Zwischenberger BA; Jacobe HT
J Am Acad Dermatol; 2011 Nov; 65(5):925-41. PubMed ID: 21645943
[TBL] [Abstract][Full Text] [Related]
6. [Localized scleroderma (morphea)].
Bono W; Dupin N
Presse Med; 2006 Dec; 35(12 Pt 2):1923-8. PubMed ID: 17159718
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
Soh HJ; Samuel C; Heaton V; Renton WD; Cox A; Munro J
Rheumatol Int; 2019 May; 39(5):933-941. PubMed ID: 30838436
[TBL] [Abstract][Full Text] [Related]
8. Morfea: revisión práctica de su diagnóstico, clasificación y tratamiento.
Rodríguez-Salgado P; García-Romero MT
Gac Med Mex; 2019; 155(5):522-531. PubMed ID: 31695234
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
Arthur M; Fett NM; Latour E; Jacobe H; Kunzler E; Florez-Pollack S; Houser J; Sharma S; Prasad S; Femia A; Stern MJ; Pappas-Taffer LK; Gaffney R; Fernandez AP; Knabel D; Cardones AR; Leung N; Laumann A; Yu JM; Zhao J; Vleugels RA; Tkachenko E; Lo K
JAMA Dermatol; 2020 May; 156(5):521-528. PubMed ID: 32236497
[TBL] [Abstract][Full Text] [Related]
10. Update on Management of Morphea (Localized Scleroderma) in Children.
George R; George A; Kumar TS
Indian Dermatol Online J; 2020; 11(2):135-145. PubMed ID: 32477969
[TBL] [Abstract][Full Text] [Related]
11. Disabling pansclerotic morphea of childhood--unusual case and management challenges.
Forsea AM; Cretu AN; Ionescu R; Giurcaneanu C
J Med Life; 2008; 1(3):348-54. PubMed ID: 20108512
[TBL] [Abstract][Full Text] [Related]
12. Juvenile Scleroderma-What has Changed in the Meantime?
Adrovic A; Sahin S; Barut K; Kasapcopur O
Curr Rheumatol Rev; 2018; 14(3):219-225. PubMed ID: 29692255
[TBL] [Abstract][Full Text] [Related]
13. Morphea and localized scleroderma in children.
Vierra E; Cunningham BB
Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
[TBL] [Abstract][Full Text] [Related]
14. [Localized scleroderma (morphea) in childhood].
Weibel L
Hautarzt; 2012 Feb; 63(2):89-96. PubMed ID: 22290277
[TBL] [Abstract][Full Text] [Related]
15. Localized scleroderma.
Tuffanelli DL
Semin Cutan Med Surg; 1998 Mar; 17(1):27-33. PubMed ID: 9512104
[TBL] [Abstract][Full Text] [Related]
16. A Case of Bullous Morphea Resistant to Methotrexate and Phototherapy Successfully Treated With Mycophenolate Mofetil.
Cuellar-Barboza A; Alberto Cardenas-De La Garza J; Daniel Villarreal-Villarreal C; Ocampo-Candiani J; Gomez-Flores M; Welsh O; Herz-Ruelas ME
J Drugs Dermatol; 2018 Oct; 17(10):1123-1125. PubMed ID: 30365594
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC
Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
[TBL] [Abstract][Full Text] [Related]
18. Morphea in Middle Anatolia, Turkey: a 5-year single-center experience.
Bulur I; Erdoğan HK; Karapınar T; Saracoglu ZN
Postepy Dermatol Alergol; 2017 Aug; 34(4):334-338. PubMed ID: 28951708
[TBL] [Abstract][Full Text] [Related]
19. Remission rates and risk factors for relapse in pediatric morphea: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG).
Bağlan E; Kızıldağ Z; Çağlayan Ş; Çakmak F; Yener GO; Özdel S; Öztürk K; Makay B; Çakan M; Ayaz NA; Sözeri B; Ünsal ŞE; Bülbül M
Clin Rheumatol; 2023 Oct; 42(10):2855-2860. PubMed ID: 37378874
[TBL] [Abstract][Full Text] [Related]
20. An Evaluation of the Performance of Current Morphea Subtype Classifications.
Prasad S; Zhu JL; Schollaert-Fitch K; Torok KS; Jacobe HT
JAMA Dermatol; 2021 Apr; 157(4):1-8. PubMed ID: 33595618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
